GB0405904D0 - Combinations of hmg-coa reductase inhibitors and x1 adrenergic receptor antagonists - Google Patents

Combinations of hmg-coa reductase inhibitors and x1 adrenergic receptor antagonists

Info

Publication number
GB0405904D0
GB0405904D0 GB0405904A GB0405904A GB0405904D0 GB 0405904 D0 GB0405904 D0 GB 0405904D0 GB 0405904 A GB0405904 A GB 0405904A GB 0405904 A GB0405904 A GB 0405904A GB 0405904 D0 GB0405904 D0 GB 0405904D0
Authority
GB
United Kingdom
Prior art keywords
hmg
combinations
receptor antagonists
coa reductase
adrenergic receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0405904A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0405904A priority Critical patent/GB0405904D0/en
Publication of GB0405904D0 publication Critical patent/GB0405904D0/en
Priority to PCT/IB2005/000574 priority patent/WO2005089804A2/en
Ceased legal-status Critical Current

Links

GB0405904A 2004-03-16 2004-03-16 Combinations of hmg-coa reductase inhibitors and x1 adrenergic receptor antagonists Ceased GB0405904D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0405904A GB0405904D0 (en) 2004-03-16 2004-03-16 Combinations of hmg-coa reductase inhibitors and x1 adrenergic receptor antagonists
PCT/IB2005/000574 WO2005089804A2 (en) 2004-03-16 2005-03-04 Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0405904A GB0405904D0 (en) 2004-03-16 2004-03-16 Combinations of hmg-coa reductase inhibitors and x1 adrenergic receptor antagonists

Publications (1)

Publication Number Publication Date
GB0405904D0 true GB0405904D0 (en) 2004-04-21

Family

ID=32117798

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0405904A Ceased GB0405904D0 (en) 2004-03-16 2004-03-16 Combinations of hmg-coa reductase inhibitors and x1 adrenergic receptor antagonists

Country Status (1)

Country Link
GB (1) GB0405904D0 (en)

Similar Documents

Publication Publication Date Title
HK1175465A1 (en) Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor nep
ZA200804907B (en) Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
IL178908A0 (en) Benzotriazine inhibitors of kinases
MA28876B1 (en) BICYCLIC AMIDES AS KINASE INHIBITORS
IL179999A (en) Compositions comprising nebivolol and an angiotensin ii receptor antagonist and uses thereof
IL180411A0 (en) Quinazolinone derivatives as parp inhibitors
ZA200704888B (en) Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
GB0611154D0 (en) Novel receptor antagonists and their methods of use
EP1711193A4 (en) IMPROVING PROFILES OF LIPID PROTEINS AND INHIBITING HMG-CoA REDUCTASE
EP1765805A4 (en) Cgrp receptor antagonists
IL184827A0 (en) Methods of using death receptor agonists and egfr inhibitors
IL159588A0 (en) Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
HK1104563A1 (en) Estrogen receptors and methods of use
ZA200710699B (en) Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor
EP1799672A4 (en) Cgrp receptor antagonists
EP1806147A4 (en) Use of immunesuppressant receptor
IL187895A0 (en) Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
EP2032145A4 (en) Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
IL192594A0 (en) Combination of triazine derivatives and hmg-coa reductase inhibitors
EP1812019A4 (en) Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia
SI1937696T1 (en) PROCESS FOR THE SYNTHESIS OF HMG-CoA REDUCTASE INHIBITORS
ZA200707359B (en) Inhibitors of neurotrypsin and determination thereof
EP2049102A4 (en) Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
HK1081843A1 (en) Pharmaceutical composition comprising reductase inhibitor hmg-coa and melatonin
GB0405904D0 (en) Combinations of hmg-coa reductase inhibitors and x1 adrenergic receptor antagonists

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)